Erratum: Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways (International Journal of Oncology (2013) 42 (1113-1119 ) DOI:10.3892/ijo.2013.1789);Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways

International Journal of Oncology

Volumn 42, Issue 3, 2013, Pages 1113-1119

  Chen, Chiachen ^a,c   Chang, Yuan Ching ^b   Lan, Michael S ^c,d   Breslin, Mary ^c,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c CHILDREN S HOSPITAL   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti apoptotic effect; Cell growth; JAK2 MEK ERK1 2 pathway; Leptin; Ovarian cancer; PI3K Akt pathway

Indexed keywords

CYCLIN D1; JANUS KINASE 2; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN MCL 1; TRYPAN BLUE;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84873692225     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3564     Document Type: Erratum

References (39)

1. Beehler GP, Sekhon M, Baker JA, Teter BE, McCann SE, Rodabaugh KJ and Moysich KB: Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 136: 2881-2886, 2006. (Pubitemid 44771790)
2. Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F and Webb PM: Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43: 690-709, 2007. (Pubitemid 46502901)
3. Ioka A, Tsukuma H, Ajiki W and Oshima A: Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci 94: 292-296, 2003. (Pubitemid 36575897)
4. Bray GA: The underlying basis for obesity: relationship to cancer. J Nutr 132: 3451S-3455S, 2002. (Pubitemid 35315819)
5. Leitzmann MF, Koebnick C, Danforth KN, Brinton LA, Moore SC, Hollenbeck AR, Schatzkin A and Lacey JV Jr: Body mass index and risk of ovarian cancer. Cancer 115: 812-822, 2009.
6. Schouten LJ, Rivera C, Hunter DJ, Spiegelman D, Adami HO, Arslan A, Beeson WL, van den Brandt PA, Buring JE, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Lacey JV Jr, Leitzmann M, Lukanova A, Marshall JR, Miller AB, Patel AV, Rodriguez C, Rohan TE, Ross JA, Wolk A, Zhang SM and Smith-Warner SA: Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 17: 902-912, 2008. (Pubitemid 351536422)
7. Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638, 2003. (Pubitemid 36459468)
8. Rodriguez C, Jacobs EJ, Patel AV, Calle EE, Feigelson HS, Fakhrabadi-Shokoohi D and Thun MJ: Jewish ethnicity and prostate cancer mortality in two large US cohorts. Cancer Causes Control 13: 271-277, 2002. (Pubitemid 34438237)
9. Pavelka JC, Brown RS, Karlan BY, Cass I, Leuchter RS, Lagasse LD and Li AJ: Effect of obesity on survival in epithelial ovarian cancer. Cancer 107: 1520-1524, 2006. (Pubitemid 44546912)
10. Key T, Appleby P, Barnes I, Reeves G; Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94: 606-616, 2002. (Pubitemid 34498648)
11. Risch HA: Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90: 1774-1786, 1998. (Pubitemid 28559889)
12. Hu X, Juneja SC, Maihle NJ and Cleary MP: Leptin -a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94: 1704-1711, 2002. (Pubitemid 35446839)
13. Chen C, Chang YC, Liu CL, Chang KJ and Guo IC: Leptin induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1. Breast Cancer Res Treat 98: 121-132, 2006. (Pubitemid 44050760)
14. Sharma D, Saxena NK, Vertino PM and Anania FA: Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr Relat Cancer 13: 629-640, 2006. (Pubitemid 43886682)
15. Somasundar P, Frankenberry KA, Skinner H, Vedula G, McFadden DW, Riggs D, Jackson B, Vangilder R, Hileman SM and Vona-Davis LC: Prostate cancer cell proliferation is influenced by leptin. J Surg Res 118: 71-82, 2004. (Pubitemid 38490519)
16. Uddin S, Bu R, Ahmed M, Abubaker J, Al-Dayel F, Bavi P and Al-Kuraya KS: Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer. Mol Cancer 8: 74, 2009.
17. Garofalo C and Surmacz E: Leptin and cancer. J Cell Physiol 207: 12-22, 2006.
18. Chen C, Chang YC, Liu CL, Liu TP, Chang KJ and Guo IC: Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Endocr Relat Cancer 14: 513-529, 2007. (Pubitemid 47242649)
19. Choi JH, Park SH, Leung PC and Choi KC: Expression of leptin receptors and potential effects of leptin on the cell growth and activation of mitogen-activated protein kinases in ovarian cancer cells. J Clin Endocrinol Metab 90: 207-210, 2005. (Pubitemid 40116659)
20. Buettner R, Mora LB and Jove R: Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945-954, 2002. (Pubitemid 35177340)
21. Heiser D, Labi V, Erlacher M and Villunger A: The Bcl-2 protein family and its role in the development of neoplastic disease. Exp Gerontol 39: 1125-1135, 2004. (Pubitemid 39024362)
22. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A and Craig RW: Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 54: 6348-6352, 1994.
23. Michels J, Johnson PW and Packham G: Mcl-1. Int J Biochem Cell Biol 37: 267-271, 2005. (Pubitemid 39330187)
24. Shigemasa K, Katoh O, Shiroyama Y, Mihara S, Mukai K, Nagai N and Ohama K: Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas. Jpn J Cancer Res 93: 542-550, 2002. (Pubitemid 34752911)
25. Kuo ML, Chuang SE, Lin MT and Yang SY: The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene 20: 677-685, 2001.
26. Leu CM, Chang C and Hu C: Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway. Oncogene 19: 1665-1675, 2000. (Pubitemid 30200968)
27. Wei LH, Kuo ML, Chen CA, Chou CH, Cheng WF, Chang MC, Su JL and Hsieh CY: The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene 20: 5799-5809, 2001.
28. Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, Buyse M and Bado A: Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-κB signaling. J Biol Chem 279: 16495-16502, 2004. (Pubitemid 38509348)
29. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al: Identification and inhibition of the ICE/CED 3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
30. Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS and Poirier GG: Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem 274: 28379-28384, 1999.
31. Knudsen KE, Diehl JA, Haiman CA and Knudsen ES: Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25: 1620-1628, 2006.
32. Wang JM, Chao JR, Chen W, Kuo ML, Yen JJ and Yang-Yen HF: The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol 19: 6195-6206, 1999. (Pubitemid 29399324)
33. Ogden CL, Carroll MD, Kit BK and Flegal KM: Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief pp1-8, 2012.
34. Flegal KM, Carroll MD, Kit BK and Ogden CL: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497, 2012.
35. Bray GA: Drug treatment of obesity. Rev Endocr Metab Disord 2: 403-418, 2001. (Pubitemid 33640589)
36. Simonin K, Brotin E, Dufort S, Dutoit S, Goux D, N'Diaye M, Denoyelle C, Gauduchon P and Poulain L: Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells. Mol Cancer Ther 8: 3162-3170, 2009.
37. Varin E, Denoyelle C, Brotin E, Meryet-Figuière M, Giffard F, Abeilard E, Goux D, Gauduchon P, Icard P and Poulain L: Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy. Carcinogenesis 31: 984-993, 2010.
38. Brotin E, Meryet-Figuière M, Simonin K, Duval RE, Villedieu M, Leroy-Dudal J, Saison-Behmoaras E, Gauduchon P, Denoyelle C and Poulain L: Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis. Int J Cancer 126: 885-895, 2010.
39. Weng C, Li Y, Xu D, Shi Y and Tang H: Specific cleavage of Mcl 1 by caspase-3 in tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J Biol Chem 280: 10491-10500, 2005. (Pubitemid 40395908)